Intermediatemolecular biology
CRISPR: Bacterial Adaptive Immunity
Overview
CRISPR-Cas is bacteria's adaptive immune system: it records viral DNA as spacers, transcribes them into guide RNAs, and Cas nucleases destroy matching invaders. This lesson covers the three stages and the diversity of Cas systems — the natural history behind the gene-editing revolution.
Learning objectives
- Describe the three stages of CRISPR immunity
- Explain spacer acquisition
- Distinguish CRISPR types
- Relate to genome editing
Adaptive immunity in bacteria
Unlike restriction enzymes (innate), CRISPR remembers: fragments of invading phage DNA are stored as 'spacers' between repeats — a heritable record of past infections.
CRISPR = genetic memory of viruses. Adaptation → expression → interference.
Stage 1: Adaptation
Cas1–Cas2 complexes capture phage DNA fragments and integrate them as new spacers at the leader end of the CRISPR array — newest memories first, in chronological order.
Cas1/Cas2 = spacer acquisition. Leader-proximal spacers are the most recent infections.
Stage 2: Expression
The array is transcribed into pre-crRNA, processed into individual crRNAs (each with one spacer guide). In Type II systems, tracrRNA assists processing and Cas9 loading.
crRNA provides specificity; Cas protein provides the cutting — guide + effector.
Stage 3: Interference
crRNA guides Cas effectors to complementary invader DNA; Cas9 cuts both strands (requiring a PAM sequence). PAM prevents self-targeting of the CRISPR array itself.
PAM = self vs. non-self discrimination. No PAM in the array, no autoimmunity.
Diversity and applications
Types I, II (Cas9), V (Cas12), VI (Cas13 — targets RNA): a vast natural toolkit. Repurposed for genome editing (see crispr article), diagnostics (SHERLOCK/DETECTR), and phage therapy.
Cas13 targets RNA — used in diagnostics; Cas9/Cas12 target DNA.
Key points
- Three stages: adaptation, expression, interference
- Spacers record past infections
- Cas1/Cas2 acquire spacers
- PAM prevents autoimmunity
- Type II = Cas9 system
Common misconceptions
✓ Truth: It's a natural bacterial immune system, discovered in 1987 and repurposed for editing in 2012.
✓ Truth: Cas9 is just Type II; Types I, V, VI use different effectors (Cas3, Cas12, Cas13).
Practice questions
Q1. New spacers are added at the:
- Leader end of the CRISPR array
- Trailer end
- Middle
- Random positions
Chronological order: newest spacers sit leader-proximal.
Q2. In Type II CRISPR, the effector nuclease is:
- Cas9
- Cas1
- Cas3
- Cas13
Cas9 guided by crRNA:tracrRNA performs the double-strand cut.
Q3. CRISPR adaptation requires:
- Cas1–Cas2
- Cas9 only
- Ribosomes
- ATP synthase
The Cas1–Cas2 integrase complex captures and inserts new spacers.
Click a question to reveal the answer and explanation.
Frequently asked questions
Describe the three stages of CRISPR immunity.
Adaptation: Cas1–Cas2 integrate phage fragments as spacers. Expression: the array is transcribed and processed into crRNAs. Interference: crRNA-guided Cas nucleases cleave matching invader nucleic acids.
What is the role of PAM?
The protospacer-adjacent motif is required for Cas9 target recognition but absent from the CRISPR array — distinguishing invader DNA (cut) from self spacers (spared).
How does CRISPR differ from restriction-modification?
Restriction is innate (fixed specificities); CRISPR is adaptive — it acquires new spacers from encountered phages, providing heritable, updatable immunity.